SNSS - Sunesis Pharmaceuticals EPS beats by $0.03 November, 12 2019 04:14 PM Viracta Therapeutics Inc Com Sunesis Pharmaceuticals (NASDAQ:SNSS): Q3 GAAP EPS of -$0.06 beats by $0.03.Cash and cash equivalents of $19.73MPress ReleaseMore news on: Sunesis Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, ,